Brind.

GSR invested $100M in MEI Pharma, Charlie Lee joined the board, and GSR began managing institutional Litecoin treasury strategy.

1 report, 1 independent Updated Jul 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

GSR invested $100M in MEI Pharma, Charlie Lee joined the board, and GSR began managing institutional Litecoin treasury strategy.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • etf.comGSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee NEW YORK, United States, July 18th, 2025, Chainwire GSR